Stock screenerAll disclosures →
EDGAR →
KRRO
Conviction 39HealthcareScan · Mon, Aug 10, 2026KRRO$13.52+2.04%
ResistanceSupportVol 14Insider sell2
2
2
Vol MA14 136.76K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price13.52
Change+2.04%
Gap+1.66%
Rel volume1.35×
Avg volume154.07K
Avg $ vol1.81M
SMA 2011.64
SMA 5012.19
SMA 20012.99
Price vs 50+10.89%
Price vs 200+4.05%
MA stackmixed
50/200 cross—
Supertrendup · 10.83
RSI (14)63
MACD hist0.29
MACD crossbull · 2d
Stoch %K / %D95 / 91
ADX (14)19
+DI / −DI30 / 15
RSI divergence—
MACD divergenceBearish
ATR %+6.66%
ADR %6.96%
52w high51.36
52w low5.28
From 52w high-73.68%
Above 52w low+156.06%
New 52w highNo
SqueezeOff
Bollinger width35.57%
%B0.95
Donchian pos94.00%
Donchian high13.76
Donchian low9.76
AVWAP (52w high)12.73
vs AVWAP high+6.22%
AVWAP (52w low)11.18
vs AVWAP low+20.90%
OBV trendFlat
Chaikin MF (20)0.14
Today vs 20d1.35×
Avg vol (14d)136.75K
Avg vol (20d)154.07K
Avg $ vol (20d)1.81M
Market cap199.09M
RS 3m (vs SPY)-2.90%
RS 6m (vs SPY)+0.70%
RS line new highNo
Trend template3/8
Technical rank60.8
1 week+25.88%
1 month-7.14%
3 months+12.20%
6 months+7.56%
1 year-14.75%
YTD+67.95%
P/E-1.70
P/B1.93
P/S—
P/FCF-2.52
EPS-12.48
Div yield—
ROE-113.60%
ROA-71.74%
Debt/Eq0.00
Current9.55
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-40.29%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value174.37M
Revenue0
Net income-18.92M
Gross profit—
Free cash flow-79.08M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out14.42M
Employees49
ListedMon, Nov 6, 2023
Free float10.55M
Float %73.2%
Short interest1.46M
Days to cover6.4d
Short volume38.7%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction39 / 100
Pattern quality—
Tech rank60.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.32
Support10.53
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in KRRO
No recent disclosed trades by Congress in KRRO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in KRRO · 4 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Aiyar Ram President and CEO · Common Stock · 2026-08-04 | Sell | 5.8K | $63K | 2026-08-04 | 2026-08-05 |
Cerio Jeffrey General Counsel · Common Stock · 2026-07-15 | Grant | 6.5K | — | 2026-07-15 | 2026-07-17 |
Chappell Todd Chief Operating Officer · Common Stock · 2026-07-15 | Grant | 7.5K | — | 2026-07-15 | 2026-07-17 |
Dolan Oliver Senior Vice President, Finance · Common Stock · 2026-07-15 | Grant | 5.5K | — | 2026-07-15 | 2026-07-17 |
Vincent Loic A Chief Scientific Officer · Common Stock · 2026-07-15 | Grant | 7.5K | — | 2026-07-15 | 2026-07-17 |
FORMELA JEAN FRANCOIS Director · Common Stock · 2026-07-06 | Sell | 817 | $11K | 2026-07-06 | 2026-07-07 |
FORMELA JEAN FRANCOIS Director · Common Stock · 2026-07-06 | Sell | 8.51K | $119K | 2026-07-06 | 2026-07-07 |
FORMELA JEAN FRANCOIS Director · Common Stock · 2026-07-02 | Sell | 85.95K | $1.2M | 2026-07-02 | 2026-07-07 |
FORMELA JEAN FRANCOIS Director · Common Stock · 2026-07-02 | Sell | 14.74K | $207K | 2026-07-02 | 2026-07-07 |
Aiyar Ram President and CEO · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in KRRO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.